Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welch, K.M.A.
Right arrow Articles by Keenan, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welch, K.M.A.
Right arrow Articles by Keenan, P. A.
NEUROLOGY 1985;35:1304
© 1985 American Academy of Neurology

Successful migraine prophylaxis with naproxen sodium

K.M.A. Welch, MD, D. J. Ellis, MD and P. A. Keenan

From the Henry Ford Hospital, Department of Neurology (Dr. Welch), Detroit. MI: Syntex Research (Dr. Ellis), Palo Alto, CA; and Baylor College of Medicine, Department of Neurology (Dr. Keenan), Houston, TX.

Naproxen sodium, a potent inhibitor of prostaglandin biosynthesis and platelet aggregation, was studied for efficacy in migraine prophylaxis in a randomized, double-blind, placebo-controlled, crossover trial. On naproxen treatment, 52% of the patients had no severe headaches, whereas 19 % had no severe headaches during placebo. Naproxen sodium was much better than placebo when patients' diaries were reviewed for severity of attacks, nausea, vomiting, activity reduction, duration of headache, and decreased use of therapeutic medication. The degree of platelet inhibition did not correlate with efficacy in preventing headache. Naproxen sodium can be recommended as a drug of first choice for migraine prevention.

Address correspondence and reprint requests to Dr. Welch, Henry Ford Hospital. Department of Neurology, 2799 West Grand Boulevard, Detroit, M1 48202.

Presented in part at the thirty-sixth annual meeting of the American Academy of Neurology, Boston, MA, April 1984.

Accepted for publication December 21, 1984.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
V. Snow, K. Weiss, E. M. Wall, C. Mottur-Pilson, and for the American Academy of Family Physicians and
Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Ann Intern Med, November 19, 2002; 137(10): 840 - 849.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K.M.A. Welch
Drug Therapy of Migraine
N. Engl. J. Med., November 11, 1993; 329(20): 1476 - 1483.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.